We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

190 hedge funds and large institutions have $457M invested in Adaptive Biotechnologies in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 69 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

1.61% less ownership

Funds ownership: 99.87% → 98.27% (-1.6%)

5% less funds holding

Funds holding: 200 → 190 (-10)

19% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 69

24% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 37

35% less capital invested

Capital invested by funds: $709M → $457M (-$251M)

98% less call options, than puts

Call options by funds: $12K | Put options by funds: $581K

Holders
190
Holders Change
-10
Holders Change %
-5%
% of All Funds
2.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
56
Reduced
69
Closed
37
Calls
$12K
Puts
$581K
Net Calls
-$569K
Net Calls Change
-$341K

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$29.6M
2
Millennium Management
Millennium Management
New York
+$3.23M
3
Ameriprise
Ameriprise
Minnesota
+$3.06M
4
Cerity Partners
Cerity Partners
New York
+$2.09M
5
Bank of America
Bank of America
North Carolina
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.3M
2
AIM
ARK Investment Management
Florida
-$8.69M
3
EHI
Eagle Health Investments
Connecticut
-$5.95M
4
Morgan Stanley
Morgan Stanley
New York
-$4.71M
5
ECM
ExodusPoint Capital Management
New York
-$3.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
76
STRS Ohio
Ohio
$264K -$20.1K -5,200 -6%
Citadel Advisors
77
Citadel Advisors
Florida
$263K +$306K +79,027 +2,753%
Corient Private Wealth
78
Corient Private Wealth
Florida
$256K -$12.5K -3,223 -4%
MSAM
79
Moloney Securities Asset Management
Missouri
$225K +$272K +70,240 New
RRCM
80
Rappaport Reiches Capital Management
Illinois
$219K – – –
AC
81
Avenir Corporation
Virginia
$213K – – –
AI
82
Atom Investors
Texas
$212K +$255K +65,964 New
UOC
83
UBS O'Connor
Illinois
$211K -$387K -100,000 -60%
DM
84
Deerfield Management
New York
$210K +$253K +65,287 New
SEI Investments
85
SEI Investments
Pennsylvania
$208K +$143 +37 +0.1%
BNP Paribas Financial Markets
86
BNP Paribas Financial Markets
France
$203K +$80.1K +20,710 +49%
Tudor Investment Corp
87
Tudor Investment Corp
Connecticut
$203K +$244K +63,132 New
CC
88
Centiva Capital
New York
$194K +$234K +60,465 New
CA
89
Crewe Advisors
Utah
$190K -$2.32K -600 -1%
MAM
90
Martingale Asset Management
Massachusetts
$188K – – –
DADC
91
D.A. Davidson & Co
Montana
$187K +$43.1K +11,150 +24%
MIM
92
MetLife Investment Management
New Jersey
$186K -$1.76K -456 -0.8%
AIG
93
American International Group
New York
$180K -$1.86K -481 -0.9%
GC
94
Guggenheim Capital
Illinois
$176K -$7.64K -1,974 -3%
Osaic Holdings
95
Osaic Holdings
Arizona
$175K -$5.08K -1,314 -2%
Renaissance Technologies
96
Renaissance Technologies
New York
$169K +$203K +52,583 New
AQR Capital Management
97
AQR Capital Management
Connecticut
$168K +$51.7K +13,350 +34%
LFP
98
Leeward Financial Partners
Washington
$166K -$9.47K -2,447 -5%
CSS
99
Cubist Systematic Strategies
Connecticut
$162K -$147K -37,981 -43%
Manulife (Manufacturers Life Insurance)
100
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$148K -$64.5K -16,680 -27%
2 3
4
5 6

ADPT Hedge Fund Activity: Q1 2024 in Review

190 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q1 2024, worth a combined $457M — down 35% from $709M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of ADPT and 28 opened new positions — a net loss of 9 holders — while 69 trimmed existing stakes and 56 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $29.6M. The largest seller was Point72 Asset Management, cutting an estimated $13.3M.

  • 190 institutional investors held Adaptive Biotechnologies (ADPT) as of Q1 2024, down from 200 in Q4 2023.
  • Funds reported $457M of Adaptive Biotechnologies stock for Q1 2024, down 35% quarter-over-quarter.
  • 28 funds opened new Adaptive Biotechnologies positions in Q1 2024 and 37 closed out, a net change of -9 holders.
  • The largest Adaptive Biotechnologies buyer in Q1 2024 was Rubric Capital Management (New York), an estimated $29.6M added.
  • The largest Adaptive Biotechnologies seller in Q1 2024 was Point72 Asset Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2024.